SAN DANIELE DEL FRIULI, Italy, July 3, 2015 /CNW/ – Lima Corporate announces the completion of the assets acquisition from Zimmer Holdings Inc. for the Zimmer® Unicompartmental High Flex Knee (ZUK) and the Biomet®Discovery™ Elbow System within the European Economic Area (EEA) and Switzerland markets, as well as the Biomet® Vanguard™ Complete Knee System for Denmark and Sweden. The products will now be fully integrated into the Lima portfolio and business units and, according to the agreement, Lima will also take over the supply chain.
“The completion of this acquisition gives Lima a big step up in the knee and extremities markets. The Zimmer® ZUK and the Biomet® Vanguard™ Complete Knee System will open doors for the rapid expansion in the knee market. We are already a market leader in total shoulder arthroplasty and the Biomet® Discovery™ Elbow System will allow us to expand our position,” said Luigi Ferrari, CEO of Lima Corporate.
“These products are characterized by great implant designs and successful long-term clinical heritage. Lima, on the other hand, brings to the table its Italian-European approach and know-how, necessary to best serve the markets – a winning combination,” Mr. Ferrari added.
“This is a very exciting day for Lima Corporate, as this year we also celebrate our 70th anniversary,” said Gabriele Lualdi, Chairman of the Board for Lima Corporate. Mr. Ferrari concluded, “We are building on the history and strengths of Lima’s capability to grow and respond to today’s quick changing environment.”
About Lima Corporate
Lima Corporate is a global medical device company providing reconstructive orthopaedic solutions to surgeons who face the challenges of improving the quality of life of their patients. Based in Italy, Lima Corporate is committed to the development of innovative products and procedures to enable surgeons to select ideal solution for every individual patient. Lima Corporate’s product range includes large joint revision and primary implants and complete extremities solutions including fixation.